George P. Stathopoulos
- Oncology top 2%
- Cancer Treatment and Pharmacology 26
- Lung Cancer Research Studies 23
- Colorectal Cancer Treatments and Studies 14
- Pancreatic and Hepatic Oncology Research 7
- Biomaterials top 5%
- Cancer Research top 5%
- Breast Cancer Treatment Studies 9
- Genetics top 5%
-
- Lung Cancer Treatments and Mutations 23
-
- Cancer therapeutics and mechanisms 12
-
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Co-authors
- Teni BoulikasE V ElliottJ. StathopoulosJ. DimitroulisD. AntoniouS. RigatosE. WiltshawDaniel Catovsky
- Cited by
- OncologyBiomaterialsCancer Research
- Partner nations
- GreeceUnited KingdomUnited States
In The Last Decade
George P. Stathopoulos
104 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 102
- Oncology 1.4k
- Biomaterials 391
- Cancer Research 395
- Genetics 279
- Pathology and Forensic Medicine 379
Countries citing papers authored by George P. Stathopoulos
This map shows the geographic impact of George P. Stathopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George P. Stathopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George P. Stathopoulos more than expected).
Fields of papers citing papers by George P. Stathopoulos
This network shows the impact of papers produced by George P. Stathopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George P. Stathopoulos. The network helps show where George P. Stathopoulos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside George P. Stathopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 7 | |
| 2 | 2010 | 1 | |
| 3 | 2010 | 3 | |
| 4 | 2008 | 13 | |
| 5 | 2006 | 22 | |
| 6 | 2006 | 61 | |
| 7 | 2006 | 39 | |
| 8 | 2006 | 20 | |
| 9 | 2005 | 20 | |
| 10 | 2005 | 12 | |
| 11 | 2004 | 1 | |
| 12 | 2004 | 50 | |
| 13 | 2004 | 6 | |
| 14 | 2003 | 18 | |
| 15 | Investigation of doxorubicin tissue toxicity: does amifostine provide chemoprotection? An experimental study. | 2002 | 8 |
| 16 | 2002 | 3 | |
| 17 | 2001 | 20 | |
| 18 | 1997 | 22 | |
| 19 | 1997 | 4 | |
| 20 | 1976 | 5 |
About George P. Stathopoulos
George P. Stathopoulos is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 105 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (26 papers), Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (23 papers), Colorectal Cancer Treatments and Studies (14 papers), Cancer therapeutics and mechanisms (12 papers), Breast Cancer Treatment Studies (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). The work is most often cited by research in Oncology (1.4k citations), Biomaterials (391 citations) and Cancer Research (395 citations). George P. Stathopoulos has collaborated with scholars based in Greece, United Kingdom and United States. Frequent co-authors include Teni Boulikas, E V Elliott, J. Stathopoulos, J. Dimitroulis, D. Antoniou, S. Rigatos, E. Wiltshaw, Daniel Catovsky, D. A. G. Galton and Michael Papamichail. Their work appears in journals such as Cell, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.